SCHEMBL762952

SCHEMBL762952

Oc1cccc2nc3c4ccccc4c4ccccc4c3nc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.72
ALDH1A1 P00352 3/20 0.70
MAPT P10636 3/20 0.70
KMT2A Q03164 3/20 0.70
GAA P10253 2/20 0.70
RAB9A P51151 2/20 0.70
NPSR1 Q6W5P4 1/20 0.70
CYP1A2 P05177 3/20 0.58
NQO2 P16083 3/20 0.55
MYC P01106 1/20 0.52
MAX P61244 1/20 0.52
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 2/20 0.41
RECQL P46063 2/20 0.41
NPC1 O15118 1/20 0.41
GLA P06280 1/20 0.41
POLB P06746 1/20 0.41
IDO1 P14902 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3181469 0.85 ACHE (1.00) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL345562 0.83 ALDH1A1 (1.00) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL13439504 0.83 ACHE (0.85) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL30618508 0.82 ACHE (0.62) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL29266809 0.82 ACHE (0.62) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL20475303 0.81 ALDH1A1 (0.95) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL13872598 0.79 ACHE (0.58) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL18805402 0.78 MYC (0.52) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL732274 0.78 MAPT (0.56) ACHEALDH1A1MAPTKMT2AGAA
SCHEMBL29581869 0.78 MAPT (0.56) ACHEALDH1A1MAPTKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138303-B2 Polymers BASF SE (DE) 2012-03-20 US disclosed
US-8138303-B2 Polymers BASF SE (DE) 2012-03-20 US disclosed
EP-1981929-B1 NOVEL POLYMERS BASF SE (DE) 2010-12-22 EP disclosed
US-20100249349-A1 Novel Polymers UDC IRELAND LIMITED (IE) 2010-09-30 US disclosed
US-20100249349-A1 Novel Polymers UDC IRELAND LIMITED (IE) 2010-09-30 US disclosed
WO-2007090773-A1 NOVEL POLYMERS CIBA HOLDING INC. (CH) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249349-A1 Novel Polymers OCIAD2, OCIAD1, SLCO4C1 ACHE 3047/4885ALDH1A1 478/4885MAPT 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.